Capital International Inc’s Vir Biotechnology VIR Stock Holding History

Capital International Inc’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,681	Closed	-$374K	–	293
2022 Q2	$374K	Sell	14,681 -24,777	-63%	-$578K	0.01%	276
2022 Q1	$1.01M	Sell	39,458 -18,742	-32%	-$556K	0.01%	268
2021 Q4	$2.44M	Buy	58,200 +1,209	+2%	+$47.4K	0.02%	245
2021 Q3	$2.48M	Sell	56,991 -3,497	-6%	-$151K	0.02%	244
2021 Q2	$2.86M	Sell	60,488 -5,098	-8%	-$232K	0.03%	247
2021 Q1	$3.36M	Sell	65,586 -17,553	-21%	-$946K	0.03%	233
2020 Q4	$2.23M	Buy	83,139 +3,634	+5%	+$118K	0.02%	244
2020 Q3	$2.73M	Buy	+79,505	New	+$3.42M	0.03%	206

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Inc's VIR Position: Q3 2022 in Review

Capital International Inc sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 14,681 shares — an estimated $374K sold.

Capital International Inc first reported a position in VIR in Q3 2020 and held it in 8 quarters. The position peaked at $3.36M in Q1 2021. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

Capital International Inc reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
Capital International Inc sold 14,681 Vir Biotechnology shares in Q3 2022, an estimated $374K.
Capital International Inc first reported a position in Vir Biotechnology in Q3 2020 and held it in 8 quarters.
Capital International Inc's Vir Biotechnology position peaked at $3.36M in Q1 2021.
220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Capital International Inc's 13F filing for Q3 2022, filed 14 Nov 2022.